Cerliponase Alfa

Records for this ingredient, by country (identity only).

ATC A16AB17 · 6 markets · 7 records

Cerliponase Alfa 6 markets · 7 records Forms

Filters

MarketAU 2 GB 1 CA 1 TW 1 EU 1 FR 1

Strength

AU 2 records · 1 shown of 1 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

30 mg/mL per mL / per unit basis not statedinjectionBRINEURA cerliponase alfa (rch) 150 mg/5 mL solution for injection vial with flushing solution vial unknown

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Brineura ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

150 mg/5 mLinjectionBrineura 150mg/5ml solution for infusion vials also in FR

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

30 mg/1 mLliquidBrineura

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

150 mg per mL / per unit basis not statedinjectionBRINEURA 150 mg solution for infusion+1倍原力150毫克輸注液

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Brineura ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

150 mg/5 mLinjectionBRINEURA 150 mg, solution pour perfusion also in GB

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

Strength / form / release	GB	CA	AU	TW	EU	FR
150 mg/5 mL injection	Brineura 150mg/5ml solution for infusion vials	not recorded	not recorded	not recorded	not recorded	BRINEURA 150 mg, solution pour perfusion
150 mg per mL / per unit basis not stated cannot compare injection	not recorded	not recorded	not recorded	BRINEURA 150 mg solution for infusion 倍原力150毫克輸注液	not recorded	not recorded
30 mg/1 mL liquid	not recorded	Brineura	not recorded	not recorded	not recorded	not recorded
30 mg/mL per mL / per unit basis not stated cannot compare injection	not recorded	not recorded	BRINEURA cerliponase alfa (rch) 150 mg/5 mL solution for injection vial with flushing solution vial	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	Brineura	not recorded	Brineura	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in GB · FR and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en GB · FR que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 GB · FR 有记录（未在本表显示）。另有 1 個規格/劑型僅在 GB · FR 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.